Clinical Trials List
2011-05-01 - 2013-03-01
Phase III
Terminated5
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 趙嘉倫 Division of General Internal Medicine
- LIAN-YU LIN Division of General Internal Medicine
- YEN-HUNG LIN Division of Cardiovascular Diseases
- JYH-MING JIMMY JUANG Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳恬恩 Division of Cardiovascular Diseases
- Shih-Sheng Chang Division of Cardiovascular Diseases
- 王宇澄 Division of Cardiovascular Diseases
- 何弘棋 Division of Cardiovascular Diseases
- 盧炯睿 Division of Cardiovascular Diseases
- 謝禮全 Division of Cardiovascular Diseases
- 楊晨佳 Division of Cardiovascular Diseases
- 陳業鵬 Division of Cardiovascular Diseases
- Po-Yen Ko Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
43 participants
-
Global
854 participants
